Cargando…

Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus

Methicillin-resistant Staphylococcus aureus (MRSA) has evolved numerous antimicrobial resistance mechanisms and is identified as a serious public health threat by the World Health Organization and U.S. Centers for Disease Control and Prevention. The glycopeptide vancomycin (VAN) remains a cornerston...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumaraswamy, Monika, Wiull, Kamilla, Joshi, Bishnu, Sakoulas, George, Kousha, Armin, Vaaje-Kolstad, Gustav, Johannessen, Mona, Hegstad, Kristin, Nizet, Victor, Askarian, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539228/ https://www.ncbi.nlm.nih.gov/pubmed/34683376 http://dx.doi.org/10.3390/microorganisms9102055

Ejemplares similares

Transcriptome Profiling of Staphylococcus aureus Associated Extracellular Vesicles Reveals Presence of Small RNA-Cargo
por: Joshi, Bishnu, et al.
Publicado: (2021)

Interaction of Antibiotics with Innate Host Defense Factors against Salmonella enterica Serotype Newport
por: Sakoulas, George, et al.
Publicado: (2017)

Staphylococcus aureus Membrane-Derived Vesicles Promote Bacterial Virulence and Confer Protective Immunity in Murine Infection Models
por: Askarian, Fatemeh, et al.
Publicado: (2018)

Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant Staphylococcus aureus Endovascular Infections?
por: Rose, Warren, et al.
Publicado: (2022)

Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus
por: Machado, Henrique, et al.
Publicado: (2021)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii
por: Sakoulas, George, et al.
Publicado: (2017)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus
por: Salazar, Michael J., et al.
Publicado: (2020)

Serine-Aspartate Repeat Protein D Increases Staphylococcus aureus Virulence and Survival in Blood
por: Askarian, Fatemeh, et al.
Publicado: (2016)

Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy
por: Dhand, Abhay, et al.
Publicado: (2012)

Novel Bacterial Metabolite Merochlorin A Demonstrates in vitro Activity against Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus
por: Sakoulas, George, et al.
Publicado: (2012)

Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus
por: Haste, Nina M., et al.
Publicado: (2012)

Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia
por: Sakoulas, George, et al.
Publicado: (2016)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization
por: Furuno, Jon P., et al.
Publicado: (2005)

Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus
por: Katayama, Yuki, et al.
Publicado: (2017)

The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017
por: Elstrøm, Petter, et al.
Publicado: (2019)

Genetic variability in the sdrD gene in Staphylococcus aureus from healthy nasal carriers
por: Ajayi, Clement, et al.
Publicado: (2018)

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023)

Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series
por: Sotozono, Chie, et al.
Publicado: (2013)

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Geriak, Matthew, et al.
Publicado: (2019)

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?
por: Othman, Hala B., et al.
Publicado: (2018)

Identifying the effect of vancomycin on health care–associated methicillin-resistant Staphylococcus aureus strains using bacteriological and physiological media
por: Rajput, Akanksha, et al.
Publicado: (2021)

255. Ticagrelor Aids Platelet-Mediated Clearance in a Refractory Staphylococcus aureus Endovascular Infection with Septic Emboli
por: Ulloa, Erlinda, et al.
Publicado: (2020)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
por: Hu, Jian, et al.
Publicado: (2013)

Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis
por: Gilbertie, Jessica, et al.
Publicado: (2022)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo
por: Shi, Jian, et al.
Publicado: (2014)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ljncidj28v3gi9klqighjphsg